购物车
- 全部删除
- 您的购物车当前为空
Adavivint (SM04690) 是选择性的典型的Wnt 信号通路抑制剂,在 SW480 细胞中,用高通量 TCF/LEF 报告基因实验,测得EC50=19.5 nM。
Adavivint (SM04690) 是选择性的典型的Wnt 信号通路抑制剂,在 SW480 细胞中,用高通量 TCF/LEF 报告基因实验,测得EC50=19.5 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 313 | 现货 | |
5 mg | ¥ 828 | 现货 | |
10 mg | ¥ 1,230 | 现货 | |
25 mg | ¥ 1,980 | 现货 | |
50 mg | ¥ 3,730 | 现货 | |
100 mg | ¥ 5,360 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 923 | 现货 |
产品描述 | Adavivint (SM04690) is a selective inhibitor of the typical Wnt signaling pathway. In SW480 cells, EC50=19.5 nM was measured using high-throughput TCF/LEF reporter gene experiments. |
靶点活性 | Wnt (SW480 cells):19.5 nM (EC50) |
体内活性 | Adavivint(SM04690)是一种新型Wnt通路抑制剂,用于治疗中度至重度膝部骨关节炎。 |
动物实验 | A high-throughput screen was performed using a cell-based reporter assay for Wnt pathway activity to develop a small molecule designated SM04690. Its properties were evaluated in bone-marrow-derived human mesenchymal stem cells (hMSCs) to assess chondrocyte differentiation and effects on cartilage catabolism by immunocytochemistry and gene expression, and glycosaminoglycan breakdown. In vivo effects of SM04690 on Wnt signaling, cartilage regeneration and protection were measured using biochemical and histopathological techniques in a rodent acute cruciate ligament tear and partial medial meniscectomy (ACLT + pMMx) OA model. |
别名 | Adavivint (SM04690) |
分子量 | 505.55 |
分子式 | C29H24FN7O |
CAS No. | 1467093-03-3 |
Smiles | CC(C)CC(=O)Nc1cncc(c1)-c1ccc2[nH]nc(-c3nc4cncc(-c5cccc(F)c5)c4[nH]3)c2c1 |
密度 | 1.365 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 33 mg/mL (65.28 mM), Sonification is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容